Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport

被引:280
作者
Zhang, SH [1 ]
Morris, ME [1 ]
机构
[1] SUNY Buffalo, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Amherst, NY 14260 USA
关键词
D O I
10.1124/jpet.102.044412
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Flavonoids are constituents of fruits, vegetables, and plant-derived beverages, as well as components in herbal-containing dietary supplements. The objective of this investigation was to characterize the effect of flavonoids on P-glycoprotein (P-gp) mediated cellular efflux and to determine the molecular mechanism( s) of the flavonoid-drug interaction. Studies were conducted in the sensitive and multidrug resistant human breast cancer cell lines MCF-7 and MDA435/LCC6 and examined the effects of the flavonoids biochanin A, morin, phloretin, and silymarin on daunomycin (DNM) accumulation and doxorubicin cytotoxicity. The potential mechanism( s) involved in the interaction was evaluated by determining flavonoid effects on 1) P-gp ATPase activity, 2) [H-3] azidopine photoaffinity labeling of P-gp, and 3) cellular P-gp levels. The flavonoids increased [H-3] DNM accumulation in P-gp positive cells, but not P-gp negative cells, and these effects were both flavonoid concentration- and P-gp expression level-dependent. Biochanin A and silymarin potentiated doxorubicin cytotoxicity in P-gp positive cells. Biochanin A and phloretin stimulated, whereas morin and silymarin inhibited P-gp ATPase activity, confirming that these flavonoids interact with P-gp. Morin and silymarin significantly inhibited [H-3] azidopine photoaffinity labeling of P-gp, suggesting a direct interaction with P-gp substrate binding. A 24-h preincubation with all flavonoids, followed by flavonoid removal, did not alter cellular P-gp level in P-gp positive cells. In conclusion, biochanin A, morin, phloretin, and silymarin all inhibited P-gp-mediated cellular efflux and the mechanism of the interaction involved, at least in part, a direct interaction. The findings of this study indicate a potential for significant flavonoid-drug interactions with P-gp substrates.
引用
收藏
页码:1258 / 1267
页数:10
相关论文
共 41 条
[21]   MDA435/LCC6 and MDA435/LCC6(MDR1): Ascites models of human breast cancer [J].
Leonessa, F ;
Green, D ;
Licht, T ;
Wright, A ;
WingateLegette, K ;
Lippman, J ;
Gottesman, MM ;
Clarke, R .
BRITISH JOURNAL OF CANCER, 1996, 73 (02) :154-161
[22]  
List AF, 1996, LEUKEMIA, V10, P937
[23]   Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833 [J].
Mayer, U ;
Wagenaar, E ;
Dorobek, B ;
Beijnen, JH ;
Borst, P ;
Schinkel, AH .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2430-2436
[24]  
Middleton E, 2000, PHARMACOL REV, V52, P673
[25]   Utilization of complementary and alternative medicine by United States adults - Results from the 1999 National Health Interview Survey [J].
Ni, HY ;
Simile, C ;
Hardy, AM .
MEDICAL CARE, 2002, 40 (04) :353-358
[26]   CLINICAL RELEVANCE OF P-GLYCOPROTEIN EXPRESSION IN HEMATOLOGICAL MALIGNANCIES [J].
NOOTER, K ;
SONNEVELD, P .
LEUKEMIA RESEARCH, 1994, 18 (04) :233-243
[27]   Indinavir concentrations and St John's wort [J].
Piscitelli, SC ;
Burstein, AH ;
Chaitt, D ;
Alfaro, RM ;
Falloon, J .
LANCET, 2000, 355 (9203) :547-548
[28]   The effect of garlic supplements on the pharmacokinetics of saquinavir [J].
Piscitelli, SC ;
Burstein, AH ;
Welden, N ;
Gallicano, KD ;
Falloon, J .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (02) :234-238
[29]  
Schinkel AH, 1998, INT J CLIN PHARM TH, V36, P9
[30]   Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities [J].
Shapiro, AB ;
Ling, V .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (01) :130-137